annual total liabilities:
$855.17M+$408.34M(+91.39%)Summary
- As of today (May 21, 2025), ANIP annual total liabilities is $855.17 million, with the most recent change of +$408.34 million (+91.39%) on December 31, 2024.
- During the last 3 years, ANIP annual total liabilities has risen by +$442.31 million (+107.13%).
- ANIP annual total liabilities is now at all-time high.
Performance
ANIP Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$848.96M-$6.21M(-0.73%)Summary
- As of today (May 21, 2025), ANIP quarterly total liabilities is $848.96 million, with the most recent change of -$6.21 million (-0.73%) on March 31, 2025.
- Over the past year, ANIP quarterly total liabilities has increased by +$411.25 million (+93.95%).
- ANIP quarterly total liabilities is now -0.89% below its all-time high of $856.58 million, reached on September 30, 2024.
Performance
ANIP quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ANIP Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +91.4% | +94.0% |
| 3 y3 years | +107.1% | +112.9% |
| 5 y5 years | +250.5% | +202.1% |
ANIP Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +107.1% | -0.9% | +112.9% |
| 5 y | 5-year | at high | +250.5% | -0.9% | +226.4% |
| alltime | all time | at high | >+9999.0% | -0.9% | >+9999.0% |
ANIP Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $848.96M(-0.7%) |
| Dec 2024 | $855.17M(+91.4%) | $855.17M(-0.2%) |
| Sep 2024 | - | $856.58M(+94.6%) |
| Jun 2024 | - | $440.14M(+0.6%) |
| Mar 2024 | - | $437.71M(-2.0%) |
| Dec 2023 | $446.82M(+6.0%) | $446.82M(+2.7%) |
| Sep 2023 | - | $435.20M(+2.4%) |
| Jun 2023 | - | $424.87M(-0.2%) |
| Mar 2023 | - | $425.74M(+1.0%) |
| Dec 2022 | $421.55M(+2.1%) | $421.55M(+4.7%) |
| Sep 2022 | - | $402.44M(-2.9%) |
| Jun 2022 | - | $414.38M(+3.9%) |
| Mar 2022 | - | $398.75M(-3.4%) |
| Dec 2021 | $412.86M(+55.5%) | $412.86M(+48.0%) |
| Sep 2021 | - | $279.05M(-3.2%) |
| Jun 2021 | - | $288.24M(+10.8%) |
| Mar 2021 | - | $260.13M(-2.0%) |
| Dec 2020 | $265.49M(+8.8%) | $265.49M(-0.7%) |
| Sep 2020 | - | $267.48M(-2.4%) |
| Jun 2020 | - | $274.05M(-2.5%) |
| Mar 2020 | - | $281.06M(+15.2%) |
| Dec 2019 | $244.00M(+4.6%) | $244.00M(+0.1%) |
| Sep 2019 | - | $243.65M(+1.8%) |
| Jun 2019 | - | $239.25M(+1.9%) |
| Mar 2019 | - | $234.68M(+0.6%) |
| Dec 2018 | $233.34M(-1.7%) | $233.34M(-5.5%) |
| Sep 2018 | - | $246.98M(+3.3%) |
| Jun 2018 | - | $239.07M(+0.3%) |
| Mar 2018 | - | $238.38M(+0.4%) |
| Dec 2017 | $237.38M(+54.9%) | $237.38M(+26.5%) |
| Sep 2017 | - | $187.67M(+2.7%) |
| Jun 2017 | - | $182.67M(-1.2%) |
| Mar 2017 | - | $184.93M(+20.7%) |
| Dec 2016 | $153.22M(+22.4%) | $153.22M(+1.8%) |
| Sep 2016 | - | $150.55M(+4.4%) |
| Jun 2016 | - | $144.22M(+9.8%) |
| Mar 2016 | - | $131.41M(+5.0%) |
| Dec 2015 | $125.18M(+4.5%) | $125.18M(-1.7%) |
| Sep 2015 | - | $127.38M(+5.6%) |
| Jun 2015 | - | $120.62M(-0.5%) |
| Mar 2015 | - | $121.25M(+1.2%) |
| Dec 2014 | $119.77M(+3285.3%) | $119.77M(+1370.5%) |
| Sep 2014 | - | $8.14M(+112.8%) |
| Jun 2014 | - | $3.83M(-16.1%) |
| Mar 2014 | - | $4.56M(+28.9%) |
| Dec 2013 | $3.54M(-66.6%) | $3.54M(-46.4%) |
| Sep 2013 | - | $6.60M(+7.0%) |
| Jun 2013 | - | $6.16M(-33.9%) |
| Mar 2013 | - | $9.33M(-12.0%) |
| Dec 2012 | $10.59M | $10.59M(-3.0%) |
| Sep 2012 | - | $10.92M(-33.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $16.37M(-1.2%) |
| Mar 2012 | - | $16.58M(-32.5%) |
| Dec 2011 | $24.56M(-4.1%) | $24.56M(-20.1%) |
| Sep 2011 | - | $30.74M(-1.6%) |
| Jun 2011 | - | $31.23M(+1.8%) |
| Mar 2011 | - | $30.67M(+19.7%) |
| Dec 2010 | $25.62M(+24.3%) | $25.62M(+0.6%) |
| Sep 2010 | - | $25.46M(+1.2%) |
| Jun 2010 | - | $25.16M(+3.5%) |
| Mar 2010 | - | $24.31M(+18.0%) |
| Dec 2009 | $20.61M(+434.8%) | $20.61M(+331.4%) |
| Sep 2009 | - | $4.78M(+28.5%) |
| Jun 2009 | - | $3.72M(+19.7%) |
| Mar 2009 | - | $3.10M(-19.4%) |
| Dec 2008 | $3.85M(+154.2%) | $3.85M(-15.7%) |
| Sep 2008 | - | $4.57M(+26.2%) |
| Jun 2008 | - | $3.62M(+23.7%) |
| Mar 2008 | - | $2.93M(+93.1%) |
| Dec 2007 | $1.52M(-64.7%) | $1.52M(-32.2%) |
| Sep 2007 | - | $2.23M(-14.4%) |
| Jun 2007 | - | $2.61M(+7.4%) |
| Mar 2007 | - | $2.43M(-43.5%) |
| Dec 2006 | $4.30M(+56.0%) | $4.30M(+152.0%) |
| Sep 2006 | - | $1.71M(-26.6%) |
| Jun 2006 | - | $2.33M(-16.7%) |
| Mar 2006 | - | $2.79M(+1.3%) |
| Dec 2005 | $2.76M(+44.5%) | $2.76M(+71.5%) |
| Sep 2005 | - | $1.61M(+3.6%) |
| Jun 2005 | - | $1.55M(-14.4%) |
| Mar 2005 | - | $1.81M(-5.0%) |
| Dec 2004 | $1.91M(+116.4%) | $1.91M(+42.7%) |
| Sep 2004 | - | $1.34M(+13.6%) |
| Jun 2004 | - | $1.18M(+2.6%) |
| Mar 2004 | - | $1.15M(+30.1%) |
| Dec 2003 | $881.20K(-29.9%) | $881.20K(+25.9%) |
| Sep 2003 | - | $700.10K(-2.8%) |
| Jun 2003 | - | $720.60K(+29.9%) |
| Mar 2003 | - | $554.90K(-55.8%) |
| Dec 2002 | $1.26M(+35.4%) | $1.26M(+81.3%) |
| Sep 2002 | - | $692.80K(-5.8%) |
| Jun 2002 | - | $735.70K(+8.5%) |
| Mar 2002 | - | $678.20K(-26.9%) |
| Dec 2001 | $927.80K(-1.4%) | $927.80K(-9.8%) |
| Sep 2001 | - | $1.03M(+9.4%) |
| Jun 2001 | - | $940.70K(+18.4%) |
| Mar 2001 | - | $794.50K(-15.6%) |
| Dec 2000 | $941.30K(+186.0%) | $941.30K(+35.0%) |
| Sep 2000 | - | $697.30K(+182.1%) |
| Jun 2000 | - | $247.20K(-13.7%) |
| Mar 2000 | - | $286.30K |
| Dec 1999 | $329.10K(-59.8%) | - |
| Dec 1998 | $817.90K | - |
FAQ
- What is ANI Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual total liabilities year-on-year change?
- What is ANI Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly total liabilities year-on-year change?
What is ANI Pharmaceuticals annual total liabilities?
The current annual total liabilities of ANIP is $855.17M
What is the all time high annual total liabilities for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual total liabilities is $855.17M
What is ANI Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ANIP annual total liabilities has changed by +$408.34M (+91.39%)
What is ANI Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ANIP is $848.96M
What is the all time high quarterly total liabilities for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly total liabilities is $856.58M
What is ANI Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ANIP quarterly total liabilities has changed by +$411.25M (+93.95%)